PubMed=12801524; DOI=10.1016/S0145-2126(02)00343-0
Kirshenbaum A.S., Akin C., Wu Y.-L., Rottem M., Goff J.P., Beaven M.A., Rao V.K., Metcalfe D.D.
Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.
Leuk. Res. 27:677-682(2003)

PubMed=20814942; DOI=10.1002/0471142735.im0737s90; PMCID=PMC2923748
Radinger M., Jensen B.M., Kuehn H.S., Kirshenbaum A.S., Gilfillan A.M.
Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood.
Curr. Protoc. Immunol. 90:7.37.1-7.37.12(2010)

DOI=10.1016/j.jaci.2013.12.226
Kirshenbaum A.S., Petrik A., Walsh R., Vepa S., Metcalfe D.D.
Worldwide impact Of LAD2 mast cell line on mast cell biology research.
J. Allergy Clin. Immunol. 133 Suppl. 1:AB57-AB57(2014)

PubMed=25149487; DOI=10.1007/978-1-4939-1173-8_8
Passante E.
Mast cell and basophil cell lines: a compendium.
Methods Mol. Biol. 1192:101-113(2014)

PubMed=25195635; DOI=10.1159/000365729; PMCID=PMC4201868
Kirshenbaum A.S., Petrik A., Walsh R., Kirby T.L., Vepa S., Wangsa D., Ried T., Metcalfe D.D.
A ten-year retrospective analysis of the distribution, use and phenotypic characteristics of the LAD2 human mast cell line.
Int. Arch. Allergy Immunol. 164:265-270(2014)

DOI=10.1016/j.jaci.2018.12.550
Kirshenbaum A.S., Yin Y., Sundstrom J.B., Bandara G., Metcalfe D.D.
Characterization and comparison of human LAD1 mast cells with human LAD2 mast cells.
J. Allergy Clin. Immunol. 143 Suppl. 1:AB180-AB180(2019)

PubMed=31698677; DOI=10.3390/ijms20225520; PMCID=PMC6888318
Kirshenbaum A.S., Yin Y.-Z., Sundstrom J.B., Bandara G., Metcalfe D.D.
Description and characterization of a novel human mast cell line for scientific study.
Int. J. Mol. Sci. 20:5520.1-5520.9(2019)